惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

N
Netflix TechBlog - Medium
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
爱范儿
爱范儿
博客园_首页
雷峰网
雷峰网
Hugging Face - Blog
Hugging Face - Blog
V
Visual Studio Blog
The Cloudflare Blog
罗磊的独立博客
美团技术团队
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
大猫的无限游戏
大猫的无限游戏
阮一峰的网络日志
阮一峰的网络日志
V
V2EX
博客园 - 叶小钗
The GitHub Blog
The GitHub Blog
Last Week in AI
Last Week in AI
J
Java Code Geeks
MyScale Blog
MyScale Blog
G
Google Developers Blog
U
Unit 42
Y
Y Combinator Blog
P
Proofpoint News Feed
Vercel News
Vercel News

Forbes - Healthcare

The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness
Humana Profits Eclipse $1 Billion As Medicare Costs Ease ...
Bruce Japsen · 2026-04-29 · via Forbes - Healthcare
Traders On The Floor Of The New York Stock Exchange As Fed Chair Powell Holds New Conference

Humana Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday, July 30, 2025. Photographer: Michael Nagle/Bloomberg

© 2025 Bloomberg Finance LP

Humana reported first quarter net income of nearly $1.2 billion as costs of care for older adults in its Medicare Advantage plans eased a bit but remained high.

Like many of its rival health insurers, the company has been battling rising medical expenses from customers in its health plans. Wednesday’s results reflected costs that are still up with the company’s benefit ratio, which is the percentage of premium revenue that goes toward medical costs, eclipsing 89%.

But Humana, which added more than 1 million enrollees in its Medicare Advantage plans this year, said its insurance segment benefit ratio of 89.4%, was “slightly favorable" to its earlier guidance of "just under 90%,” the company said Wednesday in its first quarter earnings report. “While it remains early, available information to date suggests that medical and pharmacy cost trends are slightly better than our expectations, across both new and existing membership.”

Medical loss ratios have risen to 90% and above for several health insurance companies as claims pile up from doctors and hospitals seeing an influx of patients with a pent up demand for medical care. The industry would prefer such ratios to be below 90% and into the mid 80s, where the industry was less than two years ago. In the first quarter of last year, Humana’s insurance segment benefit ratio was 87.4%.

Humana reported net income of $1.18 billion, or $9.83 a share, which was slightly lower than the first quarter of last year when the company had net income of $1.24 billion, or $10.30 a share.

Humana affirmed its annual adjusted earnings per share of “at least $9” but lowered its reported earnings per share guidance to “’at least $8.36’ from a previous estimate of 'at least $8.89,’” the company said.

Revenue jumped to $39.6 billion compared to $32.1 billion in the year-ago quarter thanks in part to a big jump in Medicare Advantage enrollment and continued growth of the company’s CenterWell health services business.

Wall Street analysts have been worried about Humana’s Medicare Advantage enrollment growth of 25% at a time rivals, including UnitedHealth Group’s UnitedHealthcare and CVS Health’s Aetna pulled such plans out counties they deemed unprofitable. Humana reported 7.1 million Medicare Advantage enrollees compared to 5.8 million in the year-ago quarter.

“We’ve had a solid start to the year and feel good about how our operating execution and transformation initiatives are setting us up for the future,” Humana president and chief executive officer Jim Rechtin said in a statement accompanying the earnings report. “We continue to make progress where it counts for customers - quality experience and outstanding care.”